Eventide Asset Management, LLC Oric Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.01 - $20.3 $8.71 Million - $14.7 Million	-724,972 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $2.42 Million - $3.83 Million	-151,976 Reduced 17.33%	724,972 $15.2 Million
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $7.76 Million - $11.3 Million	446,948 Added 103.94%	876,948 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $8.74 Million - $17.1 Million	430,000 New	430,000 $14.6 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.